NCT05081440Unknown不适用
A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center(START-CHC)
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 5,000
- 主要终点
- primary outcome
研究概览
简要总结
A multi-center, prospective, observational Study to describe the siTuation of blood lipid mAnagement among the population with hypeRtension and/or type 2 diabeTes in Community Health Center
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The informed consent form (ICF) should be signed before conducting any research-related operations
- •Age ≥18 years
- •Patients with well-diagnosed hypertension (HTN) and/or type 2 diabetes (T2DM) and have been ill for ≥ 3 months
- •The patient underwent fasting lipid analysis in the past 1 month and the data was fully recorded
排除标准
- •1.Patients with well-diagnosed atherosclerotic cardiovascular disease (ASCVD)
- •Have received any form of lipid-lowering treatment within 4 weeks before the screening period
- •The patient is currently participating in any other clinical trial except this study
结局指标
主要结局
primary outcome
时间窗: 2022.12.01
To evaluate the blood lipid levels and current status of drug treatment in patients with CHC hypertension and/or type 2 diabetes Describe the characteristics of blood lipid treatment in patients with CHC with hypertension and/or type 2 diabetes with LDL-C between 2.6 and 4.1 mmol/L
次要结局
- secondary outcome(2022.12.01)
研究者
相似试验
进行中（未招募）
不适用
A Study to Evaluate the Efficacy and Safety of CREZET TabletDyslipidemiasNCT05889143Daewoong Pharmaceutical Co. LTD.15,000
尚未招募
Unknown
Study of lipid profile in Decomensated chronic liver disease patientsCTRI/2024/08/072578Jay Bhadja
招募中
4 期
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMIMyocardial Infarction, AcuteMyocardial StrainArterial StiffnessQuality of LifeNCT04347434Penza State University300
已完成
3 期
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)Mixed HyperlipidemiaNCT00289900Merck Sharp & Dohme LLC2,340
已完成
3 期
A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)HypercholesterolemiaNCT00092651Organon and Co1,398